CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 270 enrolled
Drug / intervention
lead placement followed by BurstDR stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03277378
NCT03277378N/ACompleted
CompareCT.gov

Randomized, Controlled, Single Blind, Prospective, Multicenter Study Evaluating Anatomic Versus Targeted Lead Placement for BurstDR Therapy During the Trial Evaluation Period. (DELIVERY)

Abbott Medical Devices·interventional·Posted Sep 11, 2017·Updated Jan 5, 2021

In Brief

A clinical study evaluating lead placement followed by BurstDR stimulation for Chronic, Intractable Pain of the Trunk and/or Lower Limbs. Completed, enrolled 270 participants across 25 sites in 7 countries.

Detailed Summary

Prospective, multi-center, randomized, single blind study

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic, Intractable Pain of the Trunk and/or Lower Limbs
CountriesAustralia, Austria, Germany, Italy, Netherlands, Sweden, United States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 11, 2017
Enrollment StartSep 22, 2017
Primary CompletionAug 23, 2018
Study CompletionOct 12, 2018
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 8.8 years ago

Interventions

lead placement followed by BurstDR stimulationdevice

lead placement followed by BurstDR stimulation